Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
Healthy Volunteers
NCT06248710

Dog Presence and Oxytocin on Trust Towards Therapists

Led by Dr. Karin Hediger · Updated on 2024-11-05

176

Participants Needed

1

Research Sites

48 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Oxytocin has been proposed as a neuroendocrine mechanism that may mediate the relationship between dog ownership and positive health outcomes and be linked to human-dog interactions and is thought to be a mechanism of interspecies bonding. While the role of oxytocin in human bonding behaviours and social behaviour, in general, is becoming well-established the role of oxytocin in human-animal interaction and Animal-Assisted Interventions (AAI) remains unclear. This research gap calls for more high-quality research investigating this possible neuroendocrine underlying mechanism to advance knowledge about AAI. If oxytocin indeed might be involved in interspecies bonding, intranasally administered oxytocin should not only enhance trust toward a human but also towards a dog.

CONDITIONS

Official Title

Dog Presence and Oxytocin on Trust Towards Therapists

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 2 18 years or older
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Fear of dogs or allergy to dog hair
  • Any acute or chronic disease such as chronic pain, hypertension, heart disease, renal disease, liver disease, diabetes, respiratory disease, or skin conditions
  • Current use of psychoactive medication, narcotics, or analgesics
  • Current psychological or psychiatric treatment
  • Drug use (THC, cocaine, heroin, etc.) within 24 hours before study appointment
  • Ongoing psychotherapy
  • Sexual intercourse within 24 hours before study appointment
  • Current respiratory diseases like influenza or asthma
  • Insufficient German language skills to understand instructions

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Basel

Basel, Canton of Basel-City, Switzerland, 4055

Actively Recruiting

Loading map...

Research Team

K

Karin Hediger, Prof. Dr.

CONTACT

E

Elena Pauli, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here